[{"Assets_0_Q3_USD":606090000.0,"CommonStockSharesOutstanding_0_Q3_shares":40564766.0,"EarningsPerShareBasic_1_Q3_USD":-0.19,"EarningsPerShareBasic_3_Q3_USD":-1.19,"NetIncomeLoss_1_Q3_USD":-7597000.0,"NetIncomeLoss_3_Q3_USD":-47206000.0,"StockholdersEquity_0_Q3_USD":264800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":39540000.0,"Ticker":"PCRX","CIK":"1396814","name":"PACIRA PHARMACEUTICALS, INC.","OfficialName":"Pacira BioSciences Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3316489486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]